참고문헌
- Garg S, Serruys PW. Coronary stents: current status. J Am Coll Cardiol 2010;56(10 Suppl):S1-S42. https://doi.org/10.1016/j.jacc.2010.06.007
- Takayama T, Hiro T, Hirayama A. Stent thrombosis and drug-eluting stents. J Cardiol 2011;58:92-98. https://doi.org/10.1016/j.jjcc.2011.07.003
- Kim SH, Hong MK. Current status of drug-eluting stents. Korean J Med 2008;75:370-382.
- Cohen M. Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ ACC/SCAI guidelines and beyond. Catheter Cardiovasc Interv 2009;74:579-597. https://doi.org/10.1002/ccd.22021
- Zamorano J, Erdine S, Pavia A, et al. Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial. Curr Med Res Opin 2011;27:821-833. https://doi.org/10.1185/03007995.2011.555754
- Panjabi S, Lacey M, Bancroft T, Cao F. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients. J Am Soc Hypertens 2013;7:46-60. https://doi.org/10.1016/j.jash.2012.11.001
- Price MJ, Angiolillo DJ, Teirstein PS, et al. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay. Impact on Thrombosis and Safety (GRAVITAS) trial. Circulation 2011;124:1132-1137. https://doi.org/10.1161/CIRCULATIONAHA.111.029165
- Ultegra Rapid Platelet Function Assay-ASA (RPFA-ASA). San Diego: Accumetrics Inc., 2002.
- Shim CY, Yoon SJ, Park S, et al. The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation. Int J Cardiol 2009;134:351-355. https://doi.org/10.1016/j.ijcard.2008.02.016
- Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399-407. https://doi.org/10.1161/HYPERTENSIONAHA.109.139816
- Devabhaktuni M, Bangalore S. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives. Vasc Health Risk Manag 2009;5:377-387.
- Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S. Single- pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens (Greenwich) 2011;13:898-909. https://doi.org/10.1111/j.1751-7176.2011.00550.x
- European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-1818. https://doi.org/10.1093/eurheartj/ehr158
- Suh JW, Lee SP, Park KW, et al. Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON- T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial. J Am Coll Cardiol 2011;57:280-289. https://doi.org/10.1016/j.jacc.2010.08.631
- Ahn SG, Lee SH, Yoon JH, et al. Different prognostic significance of high on-treatment platelet reactivity as assessed by the VerifyNow P2Y12 assay after coronary stenting in patients with and without acute myocardial infarction. JACC Cardiovasc Interv 2012;5:259-267. https://doi.org/10.1016/j.jcin.2011.12.009
- Jin HY, Yang TH, Kim DI, et al. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting. Int J Cardiol 2013;167:1877-1881. https://doi.org/10.1016/j.ijcard.2012.04.154
- Campo G, Parrinello G, Ferraresi P, et al. Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol 2011;57:2474-2483. https://doi.org/10.1016/j.jacc.2010.12.047
피인용 문헌
- Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice vol.32, pp.5, 2014, https://doi.org/10.3904/kjim.2016.391